Alexander Y. Walley, MD
Associate Professor
Boston University School of Medicine
Dept of Medicine
General Internal Medicine

MD, Johns Hopkins University School of Medicine
MSc, Boston University School of Public Health




Dr. Walley is the Director of the Boston University Addiction Medicine Fellowship Program and the Inpatient Addiction Medicine Consult Service at Boston Medical Center (BMC). He is a general internist and addiction expert who provides primary care for HIV-infected patients at BMC. His research interests include the medical complications of drug use, specifically HIV and overdose, the treatment of addictions with behavioral and pharmacologic interventions, and risk behaviors among HIV-infected people and people with HIV risk behaviors. He is an investigator on studies of the integration of addiction treatment into primary medical care and the implementation of an opioid overdose prevention programs.

He directs and founded a clinical program (FAST PATH) that integrates addiction treatment, into the medical care of patients who are HIV-infected or high-risk for HIV infection at Boston Medical Center. He founded the buprenorphine treatment program at Dimock Community Health Center in 2005. He previously served as the medical director of the Boston Public Health Commission methadone maintenance program. He is the medical director for the Massachusetts Department of Public Health’s Opioid Overdose Prevention Pilot Program. He completed a two year fellowship in general internal medicine in June 2007 and during that time he earned a Masters of Science degree in Epidemiology from BUSPH.

Courtesy Staff Privileges
Boston Medical Center
Medicine



2012 Association for Medical Education and Research in Substance Abuse: New Investigator/Educator Award
2011 Department of Medicine, Boston University School of Medicine: Junior Faculty Mentoring Award
2011 Department of Medicine, Boston University School of Medicine: Evans Junior Faculty Merit Award
2010 New England Region Society of General Internal Medicine: Clinician Investigator Award



Effectiveness of the Consult for Addiction Treatment and Care in Hospitals …
03/15/2018 - 12/31/2021 (PI)
New York University NIH-NIDA
1R01DA045669-01

Pharmacy Naloxone Distribution: Assessing a New Tool to Reduce Overdose Morta…
05/01/2016 - 01/31/2021 (PI)
West Virginia University NIH-NIDA

Pharmacy Naloxone Distribution: Assessing a New Tool to Reduce Overdose Mortality
05/01/2016 - 01/31/2021 (PI)
Pacific Institute For Res And Evaluation NIH-NIDA

Knock and Talk: Public Health-Public Safety Partnerships for Post-Overdose Outreach and Prevention
09/30/2018 - 09/29/2020 (PI)
CDC-NCIPC
1R01CE003052-01

Implementation to Motivate Physician to Opioid Dependence on HIV Setting
10/01/2015 - 03/31/2020 (PI)
Bay State Medical NIH-NIDA
5R01DA038082-05

Implementation to Motivate Physician to Opioid Dependence on HIV Setting
07/01/2014 - 06/30/2019 (PI)
Rhode Island Hospital NIH-NIDA

REBOOT- Repeated-dose behavioral intervention to reduce opioid overdose: a two-site randomized…
06/15/2018 - 03/31/2019 (PI)
Heluna Health, the new PHFE NIH-NIDA

Forecasting the Impact of Corrections-based MOUD in Massachusetts(FICOMM)
12/01/2017 - 12/31/2018 (PI)
University of Baltimore Office of National D

Addictions Medicine Fellowship
12/01/2016 - 12/31/2017 (PI)
American Board of Addiction Medicine Foundation

Opioid Overdose Prevention Pilot Program
08/01/2014 - 12/31/2016 (PI)
DPH

Showing 10 of 12 results. Show All Results


Yr Title Project-Sub Proj Pubs
2018 Knock and Talk: Public Health-Public Safety Partnerships for Post-Overdose Outreach and Prevention 1R01CE003052-01
2011 Facilitated Access to Substance Abuse Treatment with Prevention and Treatment of 5H79TI018710-05
2010 Impact of overdose prevention education and intranasal naloxone on fatal and non- 5R21CE001602-02 3
2010 Facilitated Access to Substance Abuse Treatment with Prevention and Treatment of 5H79TI018710-04
2009 Impact of overdose prevention education and intranasal naloxone on fatal and non- 1R21CE001602-01 3
2009 Facilitated Access to Substance Abuse Treatment with Prevention and Treatment of 5H79TI018710-03
2008 Facilitated Access to Substance Abuse Treatment with Prevention and Treatment of 5H79TI018710-02
2007 Facilitated Access to Substance Abuse Treatment with Prevention and Treatment of 1H79TI018710-01
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Blokhina E, Krupitsky EM, Cheng DM, Walley AY, Toussova O, Yaroslavtseva T, Gnatienko N, Bridden C, Forman LS, Bendiks S, Samet JH. Evolution of illicit opioid use among people with HIV infection in St Petersburg, Russia, in the period 2004-2015. HIV Med. 2019 Apr 29.View Related Profiles. PMID: 31034141.
     
  2. Stopka TJ, Amaravadi H, Kaplan AR, Hoh R, Bernson D, Chui KKH, Land T, Walley AY, LaRochelle MR, Rose AJ. Opioid overdose deaths and potentially inappropriate opioid prescribing practices (PIP): A spatial epidemiological study. Int J Drug Policy. 2019 Apr 10; 68:37-45.View Related Profiles. PMID: 30981166.
     
  3. Samet JH, Blokhina E, Cheng DM, Walley AY, Lioznov D, Gnatienko N, Quinn EK, Bridden C, Chaisson CE, Toussova O, Gifford AL, Raj A, Krupitsky E. A strengths-based case management intervention to link HIV-positive PWID in Russia to HIV care - results from a randomized controlled trial. AIDS. 2019 Apr 05.View Related Profiles. PMID: 30964750.
     
  4. Kimmel SD, Jawa R, Walley AY, Barlam TF. Actions to Integrate Treatment of Opioid and Infectious Disease Epidemics. Ann Intern Med. 2019 Apr 02; 170(7):508-509.View Related Profiles. PMID: 30934072.
     
  5. Larochelle MR, Stopka TJ, Xuan Z, Liebschutz JM, Walley AY. Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Mortality. Ann Intern Med. 2019 Mar 19; 170(6):430-431.View Related Profiles. PMID: 30884508; DOI: 10.7326/L18-0685;.
     
  6. Walley AY, Wakeman SE, Eng G. Case 6-2019: A 29-Year-Old Woman with Nausea, Vomiting, and Diarrhea. N Engl J Med. 2019 02 21; 380(8):772-779. PMID: 30786192.
     
  7. McNeely J, Troxel AB, Kunins HV, Shelley D, Lee JD, Walley A, Weinstein ZM, Billings J, Davis NJ, Marcello RK, Schackman BR, Barron C, Bergmann L. Study protocol for a pragmatic trial of the Consult for Addiction Treatment and Care in Hospitals (CATCH) model for engaging patients in opioid use disorder treatment. Addict Sci Clin Pract. 2019 Feb 19; 14(1):5.View Related Profiles. PMID: 30777122; DOI: 10.1186/s13722-019-0135-7;.
     
  8. Donovan E, Case P, Bratberg JP, Baird J, Burstein D, Walley AY, Green TC. Beliefs Associated with Pharmacy-Based Naloxone: a Qualitative Study of Pharmacy-Based Naloxone Purchasers and People at Risk for Opioid Overdose. J Urban Health. 2019 Feb 11. PMID: 30747371.
     
  9. Tsui JI, Walley AY, Cheng DM, Lira MC, Liebschutz JM, Forman LS, Sullivan MM, Colasanti J, Root C, O'Connor K, Shanahan CW, Bridden CL, Del Rio C, Samet JH. Provider opioid prescribing practices and the belief that opioids keep people living with HIV engaged in care: a cross-sectional study. AIDS Care. 2019 Jan 11; 1-5.View Related Profiles. PMID: 30632790; DOI: 10.1080/09540121.2019.1566591;.
     
  10. Colasanti J, Lira MC, Cheng DM, Liebschutz JM, Tsui JI, Forman LS, Sullivan M, Walley AY, Bridden C, Root C, Podolsky M, Abrams C, Outlaw K, Harris CE, Armstrong WS, Samet JH, Del Rio C. Chronic Opioid Therapy in People Living With Human Immunodeficiency Virus: Patients' Perspectives on Risks, Monitoring, and Guidelines. Clin Infect Dis. 2019 Jan 07; 68(2):291-297.View Related Profiles. PMID: 29860411.
     
Showing 10 of 98 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 98 publications over 15 distinct years, with a maximum of 17 publications in 2017

YearPublications
20001
20051
20072
20085
20092
20102
20112
20126
20137
201411
20158
201611
201717
201813
201910
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

AIDS
Heroin
HIV
Methadone
Naloxone
Overdose
Suboxone

Available to Mentor as: (Review Mentor Role Definitions):
  • Advisor
  • Career Mentor
  • Co-Mentor or Peer Mentor
  • Project Mentor
  • Research / Scholarly Mentor
Contact for Mentoring:


Dr. Alex Walley of the Grayken Center Addiction at BMC

All About Boston 2/14/2019

Expanding Access to Naloxone

Apa's Medical Mind 1/10/2019

Nurse Denied Life Insurance Coverage Because She Specializes In Addiction Treatment

Inquisitr 12/15/2018

Nurse Denied Life Insurance Because She Carries Naloxone

NPR Shots 12/13/2018

Markey Demands Details About Life Insurance Denials For Carrying Naloxone

WBUR 12/10/2018

Life Insurers Declining Coverage For Those Who Purchase Naloxone

Becker’s Hospital Review 12/6/2018

Knocking On Doors To Get Opioid Overdose Survivors Into Treatment

NPR 10/24/2018

Knocking On Doors To Get Opioid Overdose Survivors Into Treatment

Texas Public Radio 10/24/2018

801 Massachusetts Ave Crosstown Center
Boston MA 02118
Google Map

617.414.6975
Download vCard

Walley's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
See all (273) concept(s)
_
Co-Authors
See all (54) people
_
Similar People
See all (60) people
_
Same Department
Search Department